Recent Articles from Investor Brand Network

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) was featured in a recent article that discussed the company’s launch of an AI-powered manufacturing services platform designed to help emerging biotechnology companies overcome one of the industry’s biggest challenges: accessing full GMP infrastructure. “The platform combines Oncotelic’s proprietary PDAOAI(TM) architecture with digital manufacturing technologies and intelligent robotics developed in collaboration with TechForce Robotics, the company’s strategic robotics and automation partner. The goal is not simply to apply AI to drug discovery, but to bring it into the manufacturing workflows that determine whether a therapy moves efficiently from development toward commercialization.”

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced publication of new preclinical research in the peer-reviewed Journal of Virology demonstrating significant differences in virulence between mpox virus clade IIb, the strain circulating in the U.S., and the historic clade IIa strain. Conducted at the company’s research and development center, the study identified three new mouse models for investigating mpox pathogenesis and found that the clade IIb isolate is up to 100,000 times less virulent than clade IIa, providing additional tools to evaluate vaccines and other medical countermeasures.

With renewable sources of energy becoming more and more ubiquitous across the world, the transition to green energy poses a unique challenge: how to electrify critical industries without contributing to the worsening global e-waste issue.

Ambiq Micro (NYSE: AMBQ) announced the closing of its upsized underwritten public offering of 2.3 million shares of common stock, including the full exercise of the underwriters’ option to purchase an additional 300,000 shares, at a public offering price of $78.00 per share. The offering generated gross proceeds of approximately $179.4 million before underwriting discounts, commissions and offering expenses.

Xeriant (OTCQB: XERI) announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 12,679,047 covering the company’s proprietary multilayered fire-resistant polymer composite and manufacturing method. The patent protects the core technology behind NEXBOARD, the company’s eco-friendly construction panel made from recycled plastic and fiber waste, and further strengthens the intellectual property supporting its DUREVER advanced materials platform.

Nuvectis Pharma (NASDAQ: NVCT) announced the pricing of its previously announced underwritten public offering of 5 million shares of common stock at $20.00 per share, generating expected gross proceeds of approximately $100 million. The company also granted the underwriters a 30-day option to purchase up to an additional 750,000 shares at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 1, 2026, subject to customary closing conditions.

Regentis Biomaterials (NYSE American: RGNT) announced it has received approval from the European Notified Body to manufacture GelrinC(R) using its next-generation solvent-free manufacturing process, a milestone that supports the product’s planned commercial launch in Europe. The company said the new process increases production yield by approximately 400%, producing five times more product from the same manufacturing volume while improving manufacturing efficiency, scalability and occupational and environmental safety. Extensive clinical testing validated consistent product quality and clinical performance.

NextPlat (NASDAQ: NXPL, NXPLW) announced an agreement to acquire an independent pharmacy in a rural community near Pensacola, Florida, for $1.5 million in cash, with the transaction expected to close during the fourth quarter of 2026, subject to customary closing conditions. The acquisition will expand the company’s PharmcoRx retail footprint into an underserved market, where it plans to introduce same-day delivery, online fulfillment and higher-margin contracted services, including support for healthcare providers participating in the federal 340B Drug Pricing Program, long-term care facilities and government agencies.

Nightfood Holdings (OTCQB: NGTF), operating as TechForce Robotics, is featured in a new AINewsWire editorial examining how the AI infrastructure buildout is driving demand beyond chips to the precision automation, robotics and semiconductor production equipment needed to manufacture them. The editorial highlights the company’s evaluation of a dual-region manufacturing expansion of up to 100,000 square feet across Taiwan and the U.S. with strategic partner Jiun Jiang Enterprise to support growing demand from semiconductor, advanced packaging and industrial automation customers.

The United States wants to remain the global leader in artificial intelligence (AI), but recent government actions have made some technology companies cautious. A new AI export program introduced by the Trump administration was designed to help American companies sell AI products and services around the world. However, the program has received a weaker response than many officials expected.

Meta has removed its newly launched Muse Image tool after facing widespread backlash over privacy concerns and automatic enrollment of public account users. The feature enrolled all public-facing profile users by default unless they manually disabled it in settings.

According to Sprott Inc.’s market strategist Paul Wong, the value of gold as a reserve asset is growing around the world as the globe slowly shifts from a unipolar system to a multipolar system . He explains that the current price swings witnessed in the gold market may mask this new reality, but a close examination of market fundamentals attests to this fact.

AINewsWire Editorial Coverage : When people talk about the AI buildout, they tend to reach for the same shorthand: chips. But the more instructive story is unfolding one level down, in the precision automation, robotics and semiconductor production equipment required to fabricate and package those chips at scale. U.S. power utilities are already racing to secure grid hardware for AI data centers, and analysts forecast global chip sales reaching $975 billion this year. Nightfood Holdings Inc. (OTCQB: NGTF) ( Profile ), operating as TechForce Robotics, is working to establish itself within that downstream layer. Last week the company reported that it is evaluating approximately 100,000 square feet of added dual-region manufacturing capacity across Taiwan and the United States, developed alongside its strategic partner Jiun Jiang Enterprise Co., Ltd. The proposed expansion is aimed at serving semiconductor, advanced packaging and industrial automation customers tied to the current wave of AI infrastructure investment. The announcement reflects the company’s ambition to build a meaningful position among the hardware and infrastructure providers powering the AI era, a sector that includes Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM), Applied Materials Inc. (NASDAQ: AMAT), Lam Research Corporation (NASDAQ: LRCX) and…

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Kairos Pharma (NYSE American: KAPA) announced favorable interim safety results from its ongoing Phase 1 trial evaluating ENV-105 (carotuximab) in combination with osimertinib (Tagrisso(R)) for patients with advanced EGFR-mutated non-small cell lung cancer (“NSCLC”) who have developed resistance to osimertinib. The company reported no Grade 3 or higher treatment-related adverse events among 13 patients treated with ENV-105 to date, supporting continued advancement of the program toward an early efficacy readout. ENV-105 is designed to inhibit CD105, a protein associated with acquired drug resistance, with the goal of restoring sensitivity to osimertinib.

BioAdaptives (OTC: BDPT) announced the upcoming commercial launch of XcellaraHeart(TM), a cardiovascular wellness supplement that combines the company’s Xcellara(TM) stem/progenitor cell mobilization formula with Tanshinone IIA, a bioactive compound derived from Danshen root. The company said the Xcellara(TM) base is supported by a randomized, double-blind, placebo-controlled clinical trial that demonstrated an average 268.8% increase in circulating primitive stem/progenitor-type cells after four weeks, while Tanshinone IIA has been studied for its effects on the SDF-1α/CXCR4 signaling pathway associated with cellular trafficking and cardiovascular repair biology.

Greenland Mines (NASDAQ: GRML) announced that independent consultant SLR Consulting (Canada) Ltd. has completed the first U.S. Securities and Exchange Commission S-K 1300-compliant Technical Report Summary for the Skaergaard project in southeast Greenland, featuring an updated 2026 Mineral Resource Estimate effective July 3, 2026. The estimate increased indicated contained palladium equivalent (“PdEq”) metal by 31% to 15.0 million ounces, boosted indicated grade by 36% to 3.04 g/t PdEq and raised inferred contained PdEq metal by 24% to 17.49 million ounces compared with the project’s 2022 resource estimate.

Beeline Holdings (NASDAQ: BLNE) the fast-growing digital mortgage platform, announced it will host a stakeholder update call to discuss its second-quarter 2026 results on Thursday, Aug. 13, 2026, at 5 p.m. ET.

Zacks Investment Research recently initiated coverage of Versus Systems (NASDAQ: VS), citing the company’s progress in strengthening its financial performance and advancing its gamification and audience engagement platform. Zacks highlighted improved first-quarter 2026 results, including significantly reduced operating losses and positive operating cash flow, along with potential growth opportunities tied to an extension of Versus’ technology licensing relationship with ASPIS. The company’s Winfinite and Filter Fan Cam platforms combine interactive games, real-world rewards, and augmented reality experiences to help brands, sports organizations, and entertainment companies increase customer engagement across digital and live-event channels. With a growing international footprint and continued product development, Versus aims to capitalize on increasing demand for interactive marketing and fan engagement solutions.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) and may include paid advertising.

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.

Earth Science Tech (OTC: ETST) recently reported a transformational fiscal 2026, highlighting continued expansion of its diversified healthcare platform, strong operational execution, and a disciplined capital allocation strategy. The company said several core businesses—including DOConsultation, Villas Health, and MOC Teledoc—are now cash-flow positive, while Peaks Curative surpassed $2 million in revenue during the first week of fiscal Q4. ETST also emphasized its debt-free growth strategy, noting that healthcare expansion, infrastructure investments, and acquisitions were completed without adding debt. In addition, the company has repurchased and retired more than 6.9 million shares since fiscal Q1 2026 to reduce dilution and enhance shareholder value. Looking ahead, ETST plans to continue expanding its healthcare operations while CEO Giorgio R. Saumat will present the company’s growth strategy at the Planet MicroCap Las Vegas 2026 Investor Conference.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Silynxcom (NYSE American: SYNX), a developer and manufacturer of ruggedized tactical communication headset devices, has completed delivery of a purchase order valued at more than $3 million to a prominent military customer in Asia. The order, originally announced in December 2025, was part of a broader tender issued by the country’s army and included the company’s flagship tactical in-ear headset systems designed to enhance situational awareness, noise cancellation and battlefield communications.

Twin Vee PowerCats (NASDAQ: VEEE), a manufacturer of power sport boats, has entered into a definitive agreement under which a subsidiary of USFM Corporation will merge with the company, while its Twin Vee and Bahama Boat Works marine business will be transferred into a privately held Delaware statutory trust. Existing shareholders will receive equity in the combined public company and contingent value rights tied to potential future distributions generated by the privatized marine business.

Blockchain Futurist Conference returns to Toronto at Rebel Entertainment Complex and Cabana on July 21-22, 2026, showcasing an immersive future world where attendees can experience real-world Web3 and AI applications firsthand. The event will feature interactive attractions including an NFT gallery, play-to-earn gaming, virtual reality experiences, blockchain-powered voting, cryptocurrency payments, metaverse exhibits, and gamified attendee engagement. Canadian startups and industry partners will showcase practical blockchain use cases spanning finance, travel, communications, and digital ownership, while organizers aim to demonstrate how emerging technologies can reshape the way people create, transact, and connect. Conference founder Tracy Leparulo said the event serves as a testing ground for innovation, helping accelerate broader adoption of Web3 technologies through hands-on experiences.

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced its inclusion in an editorial published by AINewsWire examining the growing demand for semiconductor manufacturing, automation and robotics infrastructure supporting the artificial intelligence industry. The feature highlights the company’s role in supplying hardware and manufacturing capabilities for the expanding AI ecosystem.

Twin Vee PowerCats (NASDAQ: VEEE) shares surged more than 370% Monday after the company announced a definitive agreement under which a subsidiary of USFM Corporation will merge with Twin Vee, while its marine business will be separated into a privately held Delaware statutory trust. Existing shareholders will receive equity in the combined public company along with contingent value rights tied to potential future distributions from the marine business, according to reporting by Emily Jarvie of Proactive .

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

The commercial and defense drone market is expanding quickly. South Korea alone has redirected roughly KRW 3.3 trillion (about $2.14 billion ) once earmarked for attack-helicopter programs toward drone procurement and authorized an additional $2.4 billion for drone-related spending. Yet much of the industry still treats unmanned aircraft as single-purpose machines. One platform is built for surveillance, another for mapping, a third for cargo, and each new mission can demand a different airframe, communications package, and control system. The result is fragmented fleets that grow harder and costlier to operate at scale. SDR Drone, Inc. (f.k.a. Hallmark Venture Group Inc. (OTC: HLLK), approaches the problem from the opposite direction, advancing a common technology architecture that moves across missions by changing payload and software rather than rebuilding the aircraft. Developed over more than three decades by South Korea-based Sundori Drone, the platform spans 13 production models across eight application domains.

Silo Pharma (NASDAQ: SILO) announced that its wholly owned subsidiary, QwikAgents, has been accepted into Advanced Micro Devices’ AMD AI Developer Program, providing access to AMD Developer Cloud credits, AI development tools, training resources and a global developer community. The company said the program is expected to accelerate development, testing, optimization and deployment of its AI agent platform across consumer and enterprise applications.

The Office of Critical Minerals and Energy Innovation, under the U.S. Department of Energy, has committed $75 million to 5 projects aimed at recovering rare earth elements and other critical minerals. The funding will be allocated under the Domestic Industrial Facilities program, with the selected projects establishing pilot-scale facilities designed to convert coal byproducts into commercially viable critical minerals, strengthening domestic processing capabilities.

China’s traction battery standards tightened on July 1, introducing new thermal runaway and fast-charging safety requirements for manufacturers. Against that regulatory shift, CATL has extended its commercial EV battery portfolio with the Tectrans II Superfast Charging Edition, targeting light commercial vehicles. The product addresses logistics operators whose electric delivery fleets are constrained by long charging windows and high asset downtime.

Not many people know that respiratory infections have been strongly linked to cardiovascular disease events, and this knowledge gap is leading to missed opportunities to use readily accessible vaccines to limit the severity and challenges arising from cardiovascular disease. Professor Colin Russell, based at the School of Medicine at Amsterdam University, explains why it is important to understand the role that respiratory infections play in cardiovascular disease.

As government representatives met in Geneva for the United Nations’ first discussions on global AI governance, environmental advocates warned that one critical issue has received little attention : the potential impact of AI on biodiversity and ecosystems.

According to an internal memo shared within Meta Platforms, the company plans to start making its own AI chips in September this year . This production is intended to ramp up the computing power available to the company to 14GW (gigawatts) by the end of 2027.

Bitcoin’s rally in July lost momentum towards the end of last week as the crypto fell below $62,000 amid renewed concerns over rising tensions in the Middle East. Investors reacted to reports suggesting that the already fragile understanding between the U.S. and Iran may have broken down, triggering a sharp sell-off across crypto.

Ford has shared new details about its future electric pickup truck, giving people a better idea of what to expect. Although the company has not revealed the truck’s official name, it has confirmed that the vehicle will be the first model built on its new Universal Electric Vehicle platform. This marks an important step in Ford’s plan to expand its electric vehicle lineup and meet the growing demand for cleaner transportation.

Artificial intelligence is becoming an increasingly important component of pharmaceutical research, with companies using machine learning to analyze complex biological data, identify drug targets and improve clinical development decisions. Against that backdrop, VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, announced a collaboration with AI-focused research partner Ardigen that is intended to strengthen development of the company’s BiTAC(R) oncology platform through AI-enabled target discovery and validation ( https://ibn.fm/yoDH5 ).

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Based in the United States, Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors and will help lead the company’s financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.

Exploring the concepts, products and innovations influencing currencies, digital assets and global finance.

Globavend Holdings (NASDAQ: GVH), an emerging cross-border e-commerce logistics provider, reported unaudited financial results for the six months ended March 31, 2026, with revenue increasing 8.0% year over year to US$14.8 million, driven by higher shipment volumes across its integrated cross-border logistics and air freight forwarding businesses. The company ended the period with approximately US$7.1 million in cash and cash equivalents, US$9.1 million in working capital and US$10.4 million in shareholders’ equity, underscoring a strong liquidity position despite higher freight costs and operating expenses during the period.

Datavault AI (NASDAQ: DVLT), a technology company focused on data valuation, monetization, governance, credentialing, digital asset infrastructure and enterprise information management solutions, has appointed CBIZ CPAs P.C. as its independent registered public accounting firm. The appointment underscores the company’s commitment to maintaining high standards of financial reporting, compliance and corporate governance as it continues supporting customers and stakeholders. Additional details regarding the appointment are available in the company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission.

Exploring the policies, markets and global events influencing currencies and the movement of money worldwide

Energy security has become more than a commodity story. It has become a geopolitical priority. Supply disruptions, regional conflicts, shipping chokepoints, and sanctions have repeatedly shown how dependent global economies remain on reliable access to oil and natural gas. While the energy transition continues to expand renewable generation, conventional hydrocarbons remain indispensable for transportation, manufacturing, aviation, defense, and petrochemicals. That reality has renewed interest in developing energy resources inside politically stable, Western-aligned jurisdictions.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care, has received a new U.S. patent covering the integration of acoustic sensing and thoracic impedance measurement into its credit card-sized, cable-free ECG device. The expanded capabilities are designed to support future applications in structural heart disease and heart failure monitoring by enabling the device to function as a digital stethoscope and assess fluid accumulation in the chest without changing its existing form factor.

NanoViricides, Inc. (NYSE American: NNVC) announced it has received National Ethics Committee approval in the Democratic Republic of the Congo (“DRC”) for a Phase II clinical trial evaluating its NV-387 oral gummies as a treatment for the current Bundibugyo ebolavirus outbreak. The company is preparing to submit a Clinical Trial Application to the DRC regulatory agency, ACOREP, and noted that NV-387 drug product is already in the country for an upcoming Phase II Mpox trial, enabling rapid trial initiation if regulatory approval is received.

For investors evaluating emerging medical technology companies, the competitive advantages behind a product can be as important as financial results. That was the focus of a recent Medsider interview with Dr. Sudhir Srivastava, founder, chairman and CEO of SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, who discussed the company’s strategy to broaden access to robotic surgery through lower-cost technology, physician training and remote surgical capabilities.

Wrap Technologies (NASDAQ: WRAP) is featured in a new NetworkNewsAudio audio press release titled, “Lock the Sensor, Lock the Response: The Power of Building the Autonomous Public-Safety Stack.” The editorial highlights the company’s integration of Frenel Imaging’s TPiCore thermal polarimetric imaging technology into its WrapShield platform, providing exclusive rights across the United States and NATO markets to support real-time detection of RF-silent threats for public safety, defense and critical infrastructure applications.

Safe Pro Group (NASDAQ: SPAI) announced it has been selected by AFWERX for a Small Business Innovation Research (“SBIR”) contract to develop a new artificial intelligence dataset using images of foreign object debris and damage (“FOD”) commonly found on U.S. Air Force and civilian airfields. The project is intended to support Department of the Air Force initiatives while expanding the company’s AI-powered computer vision technology into defense and commercial airfield operations.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

Safe Pro Group (NASDAQ: SPAI) announced it has been selected by AFWERX for a Small Business Innovation Research (“SBIR”) contract to develop a new artificial intelligence dataset using images of foreign object debris and damage (“FOD”) commonly found on U.S. Air Force and civilian airfields. The project is intended to support Department of the Air Force initiatives while expanding the company’s AI-powered computer vision technology into defense and commercial airfield operations.

Olenox Industries (NASDAQ: OLOX) announced the completion of its acquisition of PsyLinks Neurotech Corp., which will operate as a wholly owned subsidiary following the transaction. Under the share exchange agreement, Olenox acquired all outstanding PsyLinks shares in exchange for approximately $500,000 in restricted common stock. PsyLinks founders Dr. Michael McLaren-Gradinaru and Dr. Ford Burles have joined Olenox as vice president of technology and vice president of product development, respectively.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced a major managed Medicare agreement for TONMYA(R) (cyclobenzaprine HCl sublingual tablets), adding approximately 9 million Medicare beneficiaries effective Jan. 1, 2027. Combined with previously announced commercial coverage agreements and broad Medicaid availability, the company said TONMYA will have pharmacy coverage reaching approximately 145 million covered lives, or 46% of the U.S. covered market, while discussions with additional commercial and Medicare payers continue.

Xeriant (OTCQB: XERI) announced additional independent laboratory testing showing its 3/8-inch NEXBOARD eco-composite construction panel outperformed traditional building materials, including drywall, MgO board, OSB, MDF and plywood, across multiple performance categories. The company said the latest results demonstrated superior impact resistance, tensile strength and water resistance while confirming low VOC emissions, competitive insulating properties and a sustainability profile that includes recycled content, recyclability and no formaldehyde off-gassing.

Artificial intelligence (AI) is changing the way people work in many countries. A new Microsoft report shows that workers in Switzerland are getting more value from AI than workers in many other parts of the world. The findings suggest that Swiss AI users are becoming more productive and are using the technology to complete work that was not possible just one year ago.

A research team investigating children’s brain tumors has found promising results combining a hormone treatment with standard chemotherapy protocols . Triiodothyronine, commonly called T3, is a medication long used to manage thyroid disorders in patients throughout the lifespan. The hormone showed enhanced effectiveness when added to conventional cancer therapy in laboratory studies and animal models.

You may have read in the news how many central banks ranging from Germany, Poland, India, Russia and Brazil have been moving their gold reserves from the New York Fed and London to vaults that they own domestically. As an investor, you may be wondering what implications this trend has for the trajectory of your gold holdings and how you should respond to this accelerating phenomenon.

AINewsWire Editorial Coverage : The AI buildout is usually described in one word: chips. But the more revealing story may be happening downstream in the specialty automation, robotics and semiconductor production equipment needed to build and package those chips at scale. U.S. power companies are already scrambling to secure basic grid equipment for AI data centers, and experts project the global semiconductor industry will reach $975 billion in sales in 2026. Nightfood Holdings Inc. (OTCQB: NGTF) ( Profile ), doing business as TechForce Robotics, sits squarely inside that downstream opportunity. Last week, the company announced it is evaluating up to 100,000 square feet of additional dual-region manufacturing capacity. That capacity would span Taiwan and the United States, built alongside its strategic partner, Jiun Jiang Enterprise Co., Ltd. (“JJ Enterprise”). The goal is to support semiconductor, advanced packaging and industrial automation customers driving this new wave of capital spending. The announcement denotes the company’s focus on strengthening its position as a key player among companies focused on providing the hardware and infrastructure that power today’s rapidly expanding AI ecosystem, including NVIDIA Corporation (NASDAQ: NVDA), Advanced Micro Devices Inc . (NASDAQ: AMD), Broadcom Inc. (NASDAQ: AVGO) and…

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, is featured in an AINewsWire editorial examining how the AI infrastructure buildout is driving demand beyond chips to the specialty automation, robotics and semiconductor production equipment needed to support manufacturing at scale. The editorial highlights Nightfood’s proposed dual-region manufacturing expansion with strategic partner Jiun Jiang Enterprise Co. Ltd. (“JJ Enterprise”) in Taiwan and the United States, positioning the company to capitalize on growing demand across semiconductor, advanced packaging and industrial automation markets.

Talent Acquisition Week(R), a leading virtual event for recruitment and HR leaders, is scheduled to take place this summer from July 27 to 30, 2026. This much-awaited gathering will bring together sourcing experts, recruiters, HR and employer branding experts, for an immersive virtual learning experience.

VERAXA Biotech (NASDAQ: VRXA) announced a collaboration with AI-driven bioinformatics company Ardigen S.A. to support development of its BiTAC(R) pipeline of T-cell engagers and future antibody-drug conjugates. The partnership will initially focus on developing AI-enabled tools to identify and prioritize synergistic dual-target combinations for VERAXA’s BiTAC platform, which is designed to improve tumor targeting while reducing off-target toxicity.

Wrap Technologies (NASDAQ: WRAP) announced it entered the third quarter of 2026 with approximately $1.2 million in international orders from customers in Brazil and India, with the associated revenue expected to be recognized during the quarter. The company said the orders reflect expanding international adoption of its BolaWrap(R) 150 restraint device and were secured before increased customer interest following the recent ATF ruling classifying the product as an instrument of restraint rather than a firearm or “any other weapon.”

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) announced the appointment of Gadi Levin as chief financial officer, effective immediately. Levin brings extensive public company experience in financial management and corporate development and will help support the company’s operational growth and capital allocation strategy. Outgoing CFO Alan Rootenberg will remain on the company’s board of directors.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.

The 17th Advancing Women’s Leadership in Pharma & Healthcare Conference will be held on August 27–28, 2026. The event is organized by Dynamic Global Events (“DGE”) at the Sonesta Philadelphia Rittenhouse Hotel in Philadelphia, Pennsylvania. The conference agenda focuses on empowering women and allies across the pharmaceutical, biotechnology, healthcare, and life sciences sectors.

VERAXA Biotech (NASDAQ: VRXA) announced the appointment of Carl von Halem as interim chief financial officer, succeeding Torsten Bürgermeister. The company said it is in the final stages of discussions with a permanent CFO candidate expected to support its next phase of expansion and operational growth, with an update to be provided in due course.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

In reaction to the ongoing conflict within the Middle East, the global energy market has once again been reminded how quickly geopolitical events can disrupt oil supplies and drive volatility across economies. Discussions surrounding the Strait of Hormuz and the strategic importance of new oil-producing regions have highlighted the need for diversified energy sources, creating a potentially favorable backdrop for Greenland Energy (NASDAQ: GLND), which is advancing exploration activities in Greenland’s Jameson Land Basin and seeking to unlock a significant frontier oil resource.